相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
Navid Khan et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Eteplirsen treatment for Duchenne muscular dystrophy Exon skipping and dystrophin production
Jay S. Charleston et al.
NEUROLOGY (2018)
Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids
Craig M. McDonald et al.
NEUROMUSCULAR DISORDERS (2018)
Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy
Thomas Meier et al.
NEUROMUSCULAR DISORDERS (2017)
Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
Annemieke Aartsma-Rus et al.
NUCLEIC ACID THERAPEUTICS (2017)
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2016)
The importance of genetic diagnosis for Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
JOURNAL OF MEDICAL GENETICS (2016)
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study
Luca Bello et al.
NEUROLOGY (2016)
Current and emerging treatment strategies for Duchenne muscular dystrophy
Jean K. Mah
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Exon skipping therapy for Duchenne muscular dystrophy
Ryszard Kole et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
Marika Pane et al.
PLOS ONE (2014)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy
Valeria Ricotti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
Jerry R. Mendell et al.
MUSCLE & NERVE (2013)
THE 6-MINUTE WALK TEST AND OTHER ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: LONGITUDINAL NATURAL HISTORY OBSERVATIONS OVER 48 WEEKS FROM A MULTICENTER STUDY
Craig M. Mcdonald et al.
MUSCLE & NERVE (2013)
THE 6-MINUTE WALK TEST AND OTHER CLINICAL ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: RELIABILITY, CONCURRENT VALIDITY, AND MINIMAL CLINICALLY IMPORTANT DIFFERENCES FROM A MULTICENTER STUDY
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids
Nathalie Goemans et al.
NEUROMUSCULAR DISORDERS (2013)
24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
Elena Stacy Mazzone et al.
PLOS ONE (2013)
Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2012)
Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy
Elaine Scott et al.
PHYSIOTHERAPY RESEARCH INTERNATIONAL (2012)
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy
Anna Mayhew et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
Duchenne Muscular Dystrophy: A 30-Year Population-Based Incidence Study
Joseph Dooley et al.
CLINICAL PEDIATRICS (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
THE 6-MINUTE WALK TEST IN DUCHENNE/BECKER MUSCULAR DYSTROPHY: LONGITUDINAL OBSERVATIONS
Craig M. McDonald et al.
MUSCLE & NERVE (2010)
THE 6-MINUTE WALK TEST AS A NEW OUTCOME MEASURE IN DUCHENNE MUSCULAR DYSTROPHY
Craig M. McDonald et al.
MUSCLE & NERVE (2010)
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy
Elena Mazzone et al.
NEUROMUSCULAR DISORDERS (2010)
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Fiona L. M. Norwood et al.
BRAIN (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Reliability of the North Star Ambulatory Assessment in a multicentric setting
E. S. Mazzone et al.
NEUROMUSCULAR DISORDERS (2009)
American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation
David J. Birnkrant et al.
CHEST (2007)
Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool
Elaine Scott et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2006)
Respiratory care of the patient with duchenne muscular dystrophy - ATS Consensus Statement
JD Finder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use
J Jeppesen et al.
NEUROMUSCULAR DISORDERS (2003)
Function and genetics of dystrophin and dystrophin-related proteins in muscle
DJ Blake et al.
PHYSIOLOGICAL REVIEWS (2002)
Changes in sirometry over time as a proanostic marker in patients with Duchenne muscular dystrophy
MF Phillips et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
分享论文
